Article
Drosophila dihydrofolate reductase mutations confer antifolate resistance to mammalian cells.
European journal of pharmacology - 4 Jan 2006
Affleck Joslynn G, Al-Batayneh Khalid M, Neumann Katerina, Cole Susan P C, Walker Virginia K
Abstract excerpt
Antifolates, such as methotrexate, are used to inhibit dihydrofolate reductase (DHFR), an enzyme essential for the biosynthesis of thymidylate, purines, and several amino acids. DHFR sequences corresponding to mutations found in a methotrexate resistant Drosophila S3 cell line (L30Q), a methotrexate resistant fly population (K31P, Q134K), as well as predicted in silico (L22R) were expressed in Chinese Hamster...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
